Gene Therapy Market Research Reports & Industry Analysis
Gene therapy is an innovative field with the potential to develop new, personalized medical treatments for previously challenging conditions. At MarketResearch.com, we are committed to providing you with comprehensive gene therapy industry reports that shed light on this fast-growing market.
Understanding the Gene Therapy Market
- Our gene therapy market research reports provide valuable insights into this dynamic field to help you understand the key factors at play, prepare for challenges, and leverage technological advancements.
- Our research collection covers various markets—such as gene therapy, precision medicine, delivery devices, and manufacturing services—with data on market size and growth projections.
- In addition, we also delve into market segmentation, key developments, industry trends, and company profiling to give you the full picture of the market.
Helping You Stay Ahead
Whether you're an experienced industry professional, a consultant, or a busy executive, our gene therapy market research reports provide valuable insights. These reports are based on reliable data and expert analysis to help you make informed business decisions. With MarketResearch.com, you can stay ahead of the competition and take advantage of emerging market opportunities.
Gene Therapy Industry Research & Market Reports
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
Global Longevity and Anti-senescence Therapy Market 2025-2029
... the longevity and anti-senescence therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Gene Vector Market Size, Share, By Vector Type, Therapeutic Area, Application, End-User, and Region - Trends, Analysis, and Forecast till 2035
... genetic disorders, cancers and infectious diseases. Gene Vector Market Report Highlights: The gene vector market size will expand to USD 2497.4 million by 2035. The market was valued at reached USD 927.2 million in 2024. ... Read More
-
Cancer Gene Therapy Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034
... to grow by 18.94% CAGR to reach market size worth USD 22.8 billion by 2034. Cancer gene therapy, a revolutionary approach to cancer treatment, harnesses the power of genetic engineering to target and destroy cancer ... Read More
-
Global Viral and Non-viral Vector Market Research Report 2024
... a CAGR of 31.84% during the forecast period 2024-2030. North American market for Viral and Non-viral Vector is estimated to increase from $ 232 million in 2023 to reach $ 1423million by 2030, at a ... Read More
-
Adeno-Associated Virus (AAV) Vectors in Gene Therapy- Pipeline Insight, 2024
... (AAV) Vectors in Gene Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. ... Read More
-
Cell and Gene Therapies - Current and Future Landscape
... gene therapies. The development of CGTs in oncology is still focused on blood cancers, but there are many solid tumor basket trials in Phase I and II. In hematology, four indications are the main focus ... Read More
-
Artificial Intelligence (AI) in Cancer
... covers market projections through 2029 and presents a competitive environment and product analysis. The report provides market estimates and forecasts based on application, cancer type and region. By application type, the market is segmented into ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Cell and Gene Therapy Tools, and Reagents: Global Markets
... end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. ... Read More
-
Specialty Excipients for Parenteral Pharmaceuticals Market - A Global and Regional Analysis: Focus on Application, End User, and Country - Analysis and Forecast, 2024-2034
... excipients for parenteral pharmaceuticals market is witnessing significant growth, driven by increasing demand for advanced drug delivery systems, particularly for biologics and complex formulations. Specialty excipients play a crucial role in parenteral formulations by ensuring ... Read More
-
Global Lentiviral Vector In Gene Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The global pharmaceutical market is 1475 billion USD in ... Read More
-
Global Gene Therapy Medicinal Products (GTMP) Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The global pharmaceutical market is 1475 billion USD in ... Read More
-
Global Cellular and Gene Therapy CDMO Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... provides a comprehensive overview by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various ... Read More
-
Global Gene Therapy Medicine Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. According to our research, the global market for medical devices is estimated at ... Read More
-
Global Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market Growth (Status and Outlook) 2024-2030
... 750.3 million in 2023. With growing demand in downstream market, the Adeno-Associated Virus (AAV) Vector-Based Gene Therapy is forecast to a readjusted size of US$ 1098.9 million by 2030 with a CAGR of 5.6% during ... Read More
-
Global Gene Therapy Drugs Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Gene Therapy Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Cell and Gene Therapy CDMO Market Forecasts to 2030 – Global Analysis By Type of Therapy (Cell Therapy, Gene Therapy and Other Type of Therapies), Service Type, Technology, End User and By Geography
... Stratistics MRC, the Global Cell and Gene Therapy CDMO Market is accounted for $6.48 billion in 2024 and is expected to reach $31.14 billion by 2030 growing at a CAGR of 29.9% during the forecast ... Read More
-
Asia Pacific Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Asia Pacific bioprocessing market was valued at US$ 5,488.87 million in 2023 and is expected ... Read More
-
North America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The North America bioprocessing market was valued at US$ 12,440.60 million in 2023 and is expected ... Read More
-
South & Central America Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The South & Central America bioprocessing market was valued at US$ 892.42 million in ... Read More
-
Middle East & Africa Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Middle East & Africa bioprocessing market was valued at US$ 314.37 million in ... Read More
-
Europe Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Europe bioprocessing market was valued at US$ 6,216.50 million in 2023 and is expected to reach ... Read More
-
Global Cell and Gene Therapy Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030
... at US$ million in 2023. With growing demand in downstream market, the Cell and Gene Therapy Drug Delivery Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % ... Read More
-
Global Cell and Gene Therapy Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Cell and Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More